Xeris Biopharma Holdings, Inc.
XERSCIK 0001867096 · Every Form 4 filed by insiders at this issuer.
Filings
5
Latest Mar 18, 2024
Unique insiders
5
Showing
5 of 5
Page 1
Top insiders
Most active reporters at Xeris Biopharma Holdings, Inc.
| Name | Roles | Filings |
|---|---|---|
| Edick Paul R | OfficerDirector | 1 |
| Hecht Beth | Officer | 1 |
| JOHNSON JOHN | Director | 1 |
| Schmid John P. | Director | 1 |
| Shannon John Patrick Jr | Officer | 1 |
All filings
5 Form 4 / 4-A filings, newest first
| Filed | Insider | Top transaction | Shares | Price | Value | |
|---|---|---|---|---|---|---|
| Mar 18, 2024 | JOHNSON JOHN Director | M | 215,600 | $1.99 | $429,044 | |
| Mar 14, 2024 | Schmid John P. Director | P | 4,500 | $2.16 | $9,720 | |
| Jan 31, 2024 | Edick Paul R See Remarks · Director | A | 1,500,000 | $0.00 | $0 | |
| Jan 31, 2024 | Hecht Beth See Remarks | A | 750,000 | $0.00 | $0 | |
| Jan 31, 2024 | Shannon John Patrick Jr See Remarks | A | 750,000 | $0.00 | $0 |
Showing 1–5 of 5
Page 1 of 1
Real-time Form 4 intelligence. Smarter insider tracking.